Table 4. Variables associated with suboptimal ART adherence.
Variables | Missed ART in last 3 months | OR1 | 95% CI2 | P-value | ||
---|---|---|---|---|---|---|
≥3 (n = 78)n | <3 (n = 444) n | |||||
Socio-demographic | ||||||
Not currently in a relationship | No | 17 | 207 | |||
Yes | 61 | 237 | 3.1 | 1.8–5.5 | <0.001 | |
Born in Australia | No | 15 | 186 | |||
Yes | 63 | 258 | 3.0 | 1.7–5.5 | <0.001 | |
Living alone | No | 35 | 276 | |||
Yes | 43 | 168 | 2.0 | 1.2–3.3 | 0.004 | |
Living in subsidized housing | No | 56 | 362 | |||
Yes | 22 | 82 | 1.7 | 1.0–3.0 | 0.047 | |
Living outside of an urban area | No | 62 | 391 | |||
Yes | 16 | 53 | 1.9 | 1.0–3.5 | 0.039 | |
HIV transmission route other than male-to-male sexual intercourse | No | 57 | 370 | |||
Yes | 21 | 74 | 1.9 | 1.1–3.2 | 0.030 | |
Finances and employment | ||||||
Medicare safety net* reached in previous 12 months | No | 49 | 343 | |||
Yes | 29 | 101 | 2.1 | 1.2–3.7 | 0.009 | |
Having no private health insurance | No | 22 | 199 | |||
Yes | 56 | 245 | 2.1 | 1.2–3.5 | 0.006 | |
Income ≤$580 per week | No | 28 | 233 | |||
Yes | 50 | 211 | 2.0 | 1.2–3.2 | 0.007 | |
Unemployed | No | 36 | 260 | |||
Yes | 42 | 184 | 1.8 | 1.1–2.9 | 0.019 | |
Required financial assistance in the previous 12 months | No | 39 | 346 | |||
Yes | 39 | 98 | 3.5 | 2.1–5.8 | <0.001 | |
Going without for financial reasons (food, rent, etc.) | No | 43 | 365 | |||
Yes | 35 | 79 | 3.8 | 2.3–6.3 | <0.001 | |
Cost was a barrier to accessing HIV healthcare | No | 61 | 390 | |||
Yes | 17 | 54 | 2 | 1.1–3.7 | 0.022 | |
ART pharmacy expenditure </ = sample mean monthly ART expenditure | No | 22 | 187 | |||
Yes | 56 | 257 | 1.9 | 1.1–3.1 | 0.021 | |
HIV healthcare and treatment access | ||||||
Primary HIV care provided by a general practitioner | No | 44 | 304 | |||
Yes | 34 | 140 | 1.7 | 1.0–2.7 | 0.037 | |
Receives home care services | No | 70 | 438 | |||
Yes | 8 | 6 | 8.3 | 2.8–24.8 | <0.001 | |
Receives drug and alcohol services | No | 74 | 439 | |||
Yes | 4 | 5 | 4.7 | 1.2–18.1 | 0.012 | |
Linked to HIV community organisation(s) | No | 56 | 389 | |||
Yes | 22 | 55 | 2.8 | 1.6–4.9 | <0.001 | |
Required other healthcare specialists in previous 12 months | No | 21 | 180 | |||
Yes | 57 | 264 | 1.9 | 1.1–3.2 | 0.023 | |
Other healthcare providers were involved in HIV management | No | 16 | 182 | |||
Yes | 62 | 262 | 2.7 | 1.5–4.8 | 0.001 | |
Having difficulty with ART pharmacy access | No | 67 | 423 | |||
Yes | 11 | 21 | 3.3 | 1.5–7.2 | 0.001 | |
Physical health | ||||||
Self-rated health status as poor/very poor | No | 56 | 378 | |||
Yes | 22 | 66 | 2.3 | 1.3–3.9 | 0.004 | |
>1 bed days for illness in previous 12 months | No | 23 | 215 | |||
Yes | 55 | 229 | 2.5 | 1.5–4.4 | 0.001 | |
≥1 unscheduled doctor visits | No | 17 | 147 | |||
Yes | 61 | 297 | 1.8 | 1.0–3.3 | 0.045 | |
≥1 overnight hospitalization in previous 12 months | No | 54 | 360 | |||
Yes | 24 | 84 | 1.9 | 1.1–3.3 | 0.017 | |
Hepatitis co-infection | No | 61 | 393 | |||
Yes | 17 | 51 | 2.1 | 1.2–4.0 | 0.013 | |
HIV diagnosis prior to 1996 | No | 38 | 271 | |||
Yes | 40 | 173 | 1.7 | 1.0–2.7 | 0.034 | |
Mental Health | ||||||
Major depressive disorder | No | 49 | 386 | |||
Yes | 29 | 58 | 3.9 | 2.3–6.7 | <0.001 | |
Alcohol and drug use (at least monthly) | ||||||
Cigarette smoking | No | 42 | 337 | |||
Yes | 36 | 107 | 2.7 | 1.6–4.4 | <0.001 | |
Marijuana | No | 52 | 376 | |||
Yes | 26 | 68 | 2.8 | 1.6–4.7 | <0.001 | |
Benzodiazepine | No | 63 | 420 | |||
Yes | 15 | 24 | 4.2 | 2.1–8.4 | <0.001 | |
Injected speed | No | 70 | 432 | |||
Yes | 8 | 12 | 4.1 | 1.6–10.4 | 0.001 | |
Injected methamphetamines | No | 71 | 428 | |||
Yes | 7 | 16 | 2.6 | 1.0–6.6 | 0.033 | |
Opiate use | No | 74 | 437 | |||
Yes | 4 | 7 | 3.4 | 1.0–11.8 | 0.044 | |
Life stressors | ||||||
Major stressful event in the previous 12 months | No | 20 | 211 | |||
Yes | 58 | 233 | 2.6 | 1.5–4.5 | <0.001 | |
HIV disclosure and stigma | ||||||
Have felt shamed/excluded /having awkward interactions since HIV diagnosis | No | 21 | 197 | |||
Yes | 57 | 247 | 2.2 | 1.3–3.7 | 0.004 | |
ART regimen, side effects, consistent use and dose adherence | ||||||
ART initiation prior to 2004 | No | 30 | 245 | |||
Yes | 48 | 199 | 2.1 | 1.3–3.4 | 0.004 | |
ART side effects | No | 25 | 200 | |||
Yes | 53 | 244 | 1.7 | 1.0–2.9 | 0.033 | |
On a multiple-tablet ART regimen | No | 15 | 143 | |||
Yes | 63 | 301 | 2.0 | 1.1–3.6 | 0.021 | |
Greater than once-daily ART dosing | No | 40 | 295 | |||
Yes | 38 | 149 | 1.8 | 1.2–3.1 | 0.010 | |
Feeling uninformed about ART when starting | No | 65 | 414 | |||
Yes | 13 | 30 | 2.7 | 1.4–5.5 | 0.004 | |
Starting ART following patient request | No | 61 | 397 | |||
Yes | 17 | 47 | 2.3 | 1.3–4.3 | 0.006 | |
ART-related necessity concerns | ||||||
Necessity concerns score > sample mean | No | 30 | 247 | |||
Yes | 48 | 197 | 2 | 1.2–3.3 | 0.005 | |
Non-ART medication consistent use and adherence | ||||||
Concomitant medication pill burden >2 pills per day | No | 31 | 249 | |||
Yes | 47 | 195 | 1.9 | 1.2–3.2 | 0.008 | |
Quality of Life | ||||||
PRO-QOL HIV score > sample mean | No | 27 | 271 | |||
Yes | 51 | 173 | 3 | 1.8–4.9 | <0.001 |
1Odds Ratio
295% Confidence Interval
*whereby medical costs—including pharmaceutical co-payments, are capped after reaching an annual threshold